Notably, CSF BDNF levels did not show an association with CSF NFL levels and MRI lesion load at baseline or during follow-up, suggesting that BDNF is linked to disease activity of MS through mechanisms that do not necessarily involve neuroaxonal loss or development of inflammatory brain lesions. The gene discussed is BDNF; the disease is myeloid sarcoma.